With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:
Collins Foods Ltd (ASX: CKF)
According to a note out of Morgans, its analysts have retained their buy rating on this KFC-focused quick service restaurant operator’s shares with a slightly reduced price target of $12.50. While the broker has trimmed its net profit forecast to reflect deferred store openings, reset German acquired store economics, and lower European same store sales assumptions, it remains very positive. This is partly due to the strong performance of the KFC Australia business and its attractive valuation. Morgans sees potential upside of over 40% for investors from current levels. The Collins Foods share price is trading at $8.56 on Monday.
NextDC Ltd (ASX: NXT)
A note out of Morgan Stanley reveals that its analysts have retained their overweight rating on this data centre operator’s shares with a trimmed price target of $19.00. The broker believes the market is underappreciating the structural growth in areas like cloud computing, GPU demand, and artificial intelligence (AI). It believes this will drive significant growth for data centre capacity, which bodes well for NextDC. In fact, it estimates that the data centre market could grow as much as 27% per annum through to 2030, under its bull case scenario. In light of this, the broker believes NextDC shares could be worth buying at current levels. The NextDC share price is fetching $14.12 at the time of writing.
Pro Medicus Ltd (ASX: PME)
Another note out of Morgans reveals that its analysts have retained their buy rating on this health imaging technology company’s shares with a reduced price target of $210.00. Morgans has been fine-tuning its financial model for Pro Medicus, which includes deliberately setting a lower bar. It notes that its remodelled estimates prioritise achievability over optimism, stage implementation revenue conservatively, and mark foreign exchange to spot. Morgans believes this is the right framework for a stock where sentiment has been fragile. That said, the broker believes Pro Medicus’ story remains untarnished, highlighting that contract news flow since February has been exceptional. This includes ~$100 million in wins and renewals, all at higher pricing, with cardiology upsell gaining traction. The Pro Medicus share price is trading at $145.57 on Monday afternoon.
The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.
Should you invest $1,000 in Collins Foods Limited right now?
Before you buy Collins Foods Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Collins Foods Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- How much could a $10,000 investment in these undervalued ASX 200 shares be worth in a year?
- Why NextDC, Viva Energy and NAB shares are catching investor interest on Monday
- Why did Morgans just lower its outlook on Collins Food and Pro Medicus shares?
- 3 under-the-radar ASX AI shares that could be the next WiseTech
- NextDC rally comes to a halt. Here’s what just dropped
Motley Fool contributor James Mickleboro has positions in Collins Foods, Nextdc, and Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Collins Foods and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.